The 20 Best Non-Small Cell Lung Cancer (NSCLC) Doctors Near Me in Michigan, US

Find the Top Non-Small Cell Lung Cancer (NSCLC) Experts and Specialists

Last Updated: 04/28/2026

Save doctors for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Already have a doctor?
Find A Second Opinion

MediFind found 1188 doctor with experience in Non-Small Cell Lung Cancer (NSCLC) near Michigan, US. Of these, 938 are Experienced, 220 are Advanced, 25 are Distinguished and 5 are Elite.

Location
LocationClose
1,188 providers found
    Elite in Non-Small Cell Lung Cancer (NSCLC)
    Elite in Non-Small Cell Lung Cancer (NSCLC)

    Henry Ford Cancer-Detroit

    2800 W Grand Blvd, 
    Detroit, MI 
    Languages Spoken:
    English
    Offers Telehealth

    Shirish Gadgeel is an Oncologist practicing medicine in Detroit, Michigan. Dr. Gadgeel is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy.

    Elite in Non-Small Cell Lung Cancer (NSCLC)
    Oncology | Internal Medicine
    Elite in Non-Small Cell Lung Cancer (NSCLC)
    Oncology | Internal Medicine

    Rogel Cancer Center

    1500 E Medical Center Dr, Floor B1 Reception E, 
    Ann Arbor, MI 
    Languages Spoken:
    English
    Offers Telehealth

    Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology.

    Elite in Non-Small Cell Lung Cancer (NSCLC)
    Oncology | Internal Medicine
    Elite in Non-Small Cell Lung Cancer (NSCLC)
    Oncology | Internal Medicine

    Brighton Center For Specialty Care

    7500 Challis Rd, Entrance1, Level 1, 
    Brighton, MI 
    Languages Spoken:
    English
    Offers Telehealth

    Angel Qin is an Oncologist and an Internal Medicine provider practicing medicine in Brighton, Michigan. Dr. Qin is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

    Are you looking for a specific type of Non-Small Cell Lung Cancer (NSCLC)?

    Common conditions include: EGFR Positive Lung Cancer, Large-Cell Lung Carcinoma, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma

    Learn about our expert tiers
    Elite in Non-Small Cell Lung Cancer (NSCLC)
    Oncology | Hematology | Internal Medicine
    Elite in Non-Small Cell Lung Cancer (NSCLC)
    Oncology | Hematology | Internal Medicine

    U Of M Internal Medicine Oncology

    1500 E Medical Center Dr, 
    Ann Arbor, MI 
    Languages Spoken:
    English

    Nithya Ramnath is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Ramnath is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Pleuropulmonary Blastoma.

    Elite in Non-Small Cell Lung Cancer (NSCLC)
    Elite in Non-Small Cell Lung Cancer (NSCLC)

    Karmanos Cancer Center

    4100 John R St, 
    Detroit, MI 
    Experience:
    17+ years
    Languages Spoken:
    English

    Hirva Mamdani is a Hematologist practicing medicine in Detroit, Michigan. She has been practicing medicine for over 17 years. Dr. Mamdani is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Pleuropulmonary Blastoma.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Radiation Oncology
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Radiation Oncology

    Rose Cancer Treatment Center

    3577 West 13 Mile Road, Suite Ll, 
    Royal Oak, MI 
    Experience:
    27+ years
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Inga Grills is a Radiation Oncologist practicing medicine in Royal Oak, Michigan. She has been practicing medicine for over 27 years. Dr. Grills is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 41 other conditions, according to our data. Her clinical expertise encompasses Arteriovenous Malformation, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Gamma Knife Radiosurgery. Dr. Grills is board certified in American Board Of Radiology. Dr. Grills is currently accepting new patients.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Hematology Oncology | Oncology
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Hematology Oncology | Oncology

    Corewell Health Medical Oncology Program - Lemmen-Holton

    145 Michigan Street Northeast, Suite 5200, 
    Grand Rapids, MI 
    Experience:
    23+ years
    Languages Spoken:
    English
    Offers Telehealth

    Manish Thakur is a Hematologist Oncology specialist and an Oncologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 23 years. Dr. Thakur is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Testicular Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC). Dr. Thakur is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Hematology | Oncology | Geriatrics
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Hematology | Oncology | Geriatrics

    Cancer & Leukemia Center

    44344 Dequindre Road, Suite 260, 
    Sterling Heights, MI 
    Experience:
    21+ years
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Andrew Muskovitz is a Hematologist and an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 21 years. Dr. Muskovitz is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 102 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Thrombocytopenia, Bone Marrow Aspiration, and Ureteroscopy. Dr. Muskovitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Muskovitz is currently accepting new patients.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Hematology | Oncology
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Hematology | Oncology

    AP MI Heme & Onc Consultants Dr Musa

    13530 Michigan Avenue, Suite 280, 
    Dearborn, MI 
    Experience:
    20+ years
    Languages Spoken:
    English, Arabic
    Accepting New Patients

    Faisal Musa is a Hematologist and an Oncologist practicing medicine in Dearborn, Michigan. He has been practicing medicine for over 20 years. Dr. Musa is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 64 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Musa is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Musa is currently accepting new patients.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)

    Hematology/Oncology Center

    6255 Inkster Road, Suite 307, 
    Garden City, MI 
    Experience:
    50+ years
    Languages Spoken:
    English, Hindi
    Accepting New Patients

    Parvez Khan is an Oncologist practicing medicine in Garden City, Michigan. He has been practicing medicine for over 50 years. Dr. Khan is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Agranulocytosis, Chronic Familial Neutropenia, Idiopathic Neutropenia, and Bone Marrow Aspiration. Dr. Khan is board certified in American Board Of Internal Medicine. Dr. Khan is currently accepting new patients.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)

    Karmanos Cancer Institute - Detroit Headquarters

    4100 John R Street, 
    Detroit, MI 
    Experience:
    27+ years
    Languages Spoken:
    English, Arabic
    Accepting New Patients

    Ammar Sukari is an Oncologist practicing medicine in Detroit, Michigan. He has been practicing medicine for over 27 years. Dr. Sukari is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Laryngeal Cancer, and Gastrostomy. Dr. Sukari is board certified in American Board Of Internal Medicine. Dr. Sukari is currently accepting new patients.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)

    Cancer & Leukemia Center

    44344 Dequindre Road, Suite 260, 
    Sterling Heights, MI 
    Experience:
    24+ years
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    George Howard is an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 24 years. Dr. Howard is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 113 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Familial Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, Bone Marrow Aspiration, and Gastrostomy. Dr. Howard is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Howard is currently accepting new patients.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)

    Oakland Medical Group - Division Of Clinical Hematology & Medical Oncology - Royal Oak

    3577 West 13 Mile Road, Suite 310, 
    Royal Oak, MI 
    Experience:
    33+ years
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Jeffrey Margolis is an Oncologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 33 years. Dr. Margolis is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 76 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, Bone Marrow Aspiration, and Endoscopy. Dr. Margolis is board certified in American Board Of Internal Medicine. Dr. Margolis is currently accepting new patients.

    Experienced in Non-Small Cell Lung Cancer (NSCLC)
    Intensive Care Medicine | Pulmonary Medicine | Internal Medicine
    Experienced in Non-Small Cell Lung Cancer (NSCLC)
    Intensive Care Medicine | Pulmonary Medicine | Internal Medicine

    OSF HealthCare - Medical Group (Pulmonology)

    3409 Ludington Street, 
    Escanaba, MI 
    Languages Spoken:
    English

    Ronald Sherman is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Escanaba, Michigan. Dr. Sherman is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Blastomycosis, and Asbestosis. Dr. Sherman is board certified in American Osteopathic Board Of Internal Medicine.

    Experienced in Non-Small Cell Lung Cancer (NSCLC)
    Experienced in Non-Small Cell Lung Cancer (NSCLC)

    OSF HealthCare - Medical Group (Primary Care)

    3409 Ludington Street Suite 104, 
    Escanaba, MI 
    Experience:
    17+ years
    Languages Spoken:
    English

    Anthony Kamerschen is a primary care provider, practicing in Family Medicine in Escanaba, Michigan. He has been practicing medicine for over 17 years. Dr. Kamerschen is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Acute Intermittent Porphyria, Acute Hepatic Porphyria (AHP), Porphyria, and Chronic Cough. Dr. Kamerschen is board certified in American Board Of Family Medicine.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Oncology | Internal Medicine
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Oncology | Internal Medicine

    Rogel Cancer Center

    1500 E Medical Center Dr, Floor B1 Reception E, 
    Ann Arbor, MI 
    Languages Spoken:
    English
    Offers Telehealth

    Bryan J. Schneider, MD is a Professor of Internal Medicine in the Division of Hematology/ Oncology at the University of Michigan, Ann Arbor, Michigan, and is the Section Head for the medical thoracic oncology team who treats lung cancer, esophageal cancer, mesothelioma, thymoma and carcinoid tumors.Dr. Schneider earned his medical degree from Indiana University in 1998. He also completed an internship and residency in internal medicine at the Indiana University School of Medicine and served as Chief Resident in 2001. He completed a fellowship in hematology/oncology at the University of Michigan. He joined the faculty at the University of Michigan as an Assistant Professor in 2005 and was an Assistant Professor at Cornell University in New York City from 2008 to 2014. He returned to the University of Michigan in 2015.Dr. Schneider is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has served as a member of the Experimental Therapeutics Study Section of the National Institutes of Health and serves on numerous other scientific medical committees. These include the ASCO thoracic guideline advisory group, and the steering committee for the National Cancer Center Network (NCCN) guidelines.Dr. Schneider has published extensively in peer-reviewed journals and has written several book chapters on the subject of lung cancer. He is married with twin boys and a cat. Dr. Schneider is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy. Dr. Schneider is board certified in Medical Oncology.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Radiation Oncology
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Radiation Oncology

    University Hospital

    1500 E Medical Center Dr, Floor B2 C490, 
    Ann Arbor, MI 
    Languages Spoken:
    English
    Offers Telehealth

    Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Pulmonary Medicine | Intensive Care Medicine | Internal Medicine
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Pulmonary Medicine | Intensive Care Medicine | Internal Medicine

    Northville Health Center

    39901 Traditions Dr, Floor 2, 
    Northville, MI 
    Languages Spoken:
    English
    Offers Telehealth

    I am an avid college and professional sports fan, with my roots in Chicago. I enjoy cycling, fitness, reading, and advocating for public health policies that reduce the risk of lung cancer. Lucky husband, and proud father of two. Undergraduate degree from the University of Illinois in Biomedical Engineering (1986), and M.D. from the University of Illinois College of medicine in Chicago (1990). Dr. Arenberg is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy. Dr. Arenberg is board certified in Critical Care Medicine and Pulmonary Disease.

    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Hematology Oncology
    Distinguished in Non-Small Cell Lung Cancer (NSCLC)
    Hematology Oncology

    Munson Healthcare Grayling Cancer And Infusion Center

    1105 Sixth Street, 
    Traverse City, MI 
    Experience:
    19+ years
    Languages Spoken:
    English
    Accepting New Patients
    Offers Telehealth

    Joshua Ruch is a Hematologist Oncology provider practicing medicine in Traverse City, Michigan. He has been practicing medicine for over 19 years. Dr. Ruch is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Ruch is board certified in American Board Of Internal Medicine, Medical Oncology - 2013 and American Board Of Internal Medicine, Hematology - 2013. Dr. Ruch is currently accepting new patients.

    Advanced in Non-Small Cell Lung Cancer (NSCLC)
    Pulmonary Medicine | Intensive Care Medicine
    Advanced in Non-Small Cell Lung Cancer (NSCLC)
    Pulmonary Medicine | Intensive Care Medicine

    Corewell Health Pulmonology - 4100 Lake Dr SE

    4100 Lake Drive Southeast, 
    Grand Rapids, MI 
    Experience:
    17+ years
    Languages Spoken:
    English, Spanish
    Offers Telehealth

    John Egan is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 17 years. Dr. Egan is rated as an Advanced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, Advanced Bronchoscopy, and Endoscopy. Dr. Egan is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine.

    Showing 1-20 of 1,188

    Last Updated: 04/28/2026

    What is the definition of Non-Small Cell Lung Cancer (NSCLC)?

    Non-small cell lung cancer (NSCLC) is the most common type of malignancy (cancer) that affects the lungs, accounting for nearly 85% of lung cancers. While there are several types of non-small cell lung cancer, the three most common types are 1) adenocarcinoma, 2) squamous cell carcinoma, and 3) large cell carcinoma.  Adenocarcinoma occurs in the outer region of the lung and is the most common form of non-small cell lung cancer in the United States. Squamous cell carcinoma occurs in the center of the lung next to the bronchus (airway) and accounts for 25% of non-small cell cancers. Large cell carcinoma occurs in any part of the lung and accounts for 10% of non-small cell lung cancers. In addition to these three common types of non-small cell lung cancer, there are some less common types: pleomorphic (variable in size and shape), carcinoid tumor, salivary gland carcinoma, and unclassified carcinoma. Non-small lung cancer is classified in the following stages: Occult stage – Cancer is undetectable (hidden). Stage 0 – Carcinoma in situ, or the earliest stage at which non-small lung cancer can be detected. Stage I – Cancer is only in the lung with no spread. Stage II – Cancer is in the lung and close lymph nodes. Stage III – Cancer is in the lung and median (middle) chest lymph nodes, which is known as locally advanced lung cancer. This stage has two subtypes: 1) Stage IIIA – Cancer has only spread to same side chest lymph nodes; and 2) Stage IIIB – Cancer has spread to opposite side chest lymph nodes, or above the collarbone. Stage IV – Advanced lung cancer that has spread to both lungs, the fluid surrounding the lungs, or other organs or parts of the body.

    When should I see a Non-Small Cell Lung Cancer (NSCLC) doctor in Michigan, US?

    There are various reasons why you may want to see a specialist, such as: 

    • Your primary care provider recommends it. 
    • Your condition requires expert knowledge and specialized care. 
    • Your symptoms persist or worsen despite treatment. 
    • You need specialized testing or procedures. 
    • You want a second opinion.  

    What should I consider when choosing a Non-Small Cell Lung Cancer (NSCLC) doctor in Michigan, US?

    It’s important to see a provider with expertise in your specific condition. Each provider profile in MediFind’s doctor database includes information on which conditions they treat, years of experience, research contributions, languages spoken, insurance plans accepted, and more.  

    How does MediFind rank Non-Small Cell Lung Cancer (NSCLC) doctors in Michigan, US?

    MediFind’s rankings are based on a variety of data sources, such as the number of articles a doctor has published in medical journals, participation in clinical trials and industry conferences, as well as the number of patients that provider sees for a given condition. Note that MediFind’s provider database is not based on user reviews, and providers do not pay to be included in the database. 

    What types of insurance are accepted by Non-Small Cell Lung Cancer (NSCLC) doctors in Michigan, US?

    Most profiles in MediFind’s doctor database include a list of insurance plans accepted by that provider. However, it’s a good idea to contact the provider’s office to make sure they still accept your insurance, then doublecheck by contacting your insurance plan to confirm they’re in network. 

    How can I book an appointment online with a Non-Small Cell Lung Cancer (NSCLC) doctor in Michigan, US?

    MediFind offers direct scheduling for certain providers using the “Request Appointment” button on that provider’s profile. If the schedule option is not available for a provider, tap the red “Show Phone Number” button on their profile to get their contact information. If you prefer to find providers who offer online scheduling, select “Schedules online” under the “Availability” category of the filter feature on the left side of the Non-Small Cell Lung Cancer (NSCLC) doctor search results page. 

    Why is it important to get a second opinion from a different Non-Small Cell Lung Cancer (NSCLC) doctor?

    Second opinions are an opportunity to confirm a diagnosis and its root cause, learn about alternative treatment options, or simply gain peace of mind. Many people, especially those with serious diagnoses, get second opinions so they can understand all their options and make informed decisions, so don’t hesitate to get one if you have any doubts or need more information or clarification regarding your care. Note that some insurance plans require second opinions, while others don’t cover second opinions, so be sure to confirm with your insurance provider first.   

    How can I prepare for my appointment with a Non-Small Cell Lung Cancer (NSCLC) doctor in Michigan, US?

    Prepare for your appointment by gathering the following items: 

    • Copies of medical records (dating back at least one year) 
    • Your medical history, including illnesses, medical conditions, surgeries, and other doctors you see 
    • Family history of disease 
    • List of current prescription drugs, over-the-counter medicines, vitamins, and herbal remedies or supplements including names and doses 
    • Allergies to medications, food, latex, insects, etc.  
    • List of questions and concerns 
    • Your insurance card 

    You might also contact the provider’s office to see if they offer transportation or childcare services or if you’re allowed to bring a loved one for support or to take notes during your visit. 

    What questions should I ask my Non-Small Cell Lung Cancer (NSCLC) doctor?

    Here are some sample questions: 

    • Can you explain in simple terms what this condition is and how it’s treated? 
    • What symptoms or side effects should I watch for? 
    • What tests will be involved, and when can I expect results? 
    • Are there other specialists I need to see? 
    • What’s the best way to reach you if I have follow-up questions? 

    How can I learn about the latest clinical trials and research advances my Non-Small Cell Lung Cancer (NSCLC) doctor may know about?

    MediFind’s Clinical Trials tool asks you a series of questions to help you narrow down your search by health condition, age, gender, location, how far you’re willing to travel, and more. Each question you answer filters down the number of trials until you find the ones that are most relevant to you. 

    MediFind’s Latest Advances tool features summaries of recent articles published in medical journals. We use cutting-edge technology to scour medical publication databases for the latest research advancements on any given condition, then we simplify this information in a way that’s useful and easy to understand. 

    Can I filter my search to show male or female Non-Small Cell Lung Cancer (NSCLC) doctors in Michigan, US?

    Look for the filter feature on the left side of the Non-Small Cell Lung Cancer (NSCLC) doctor search results page. Select “Female” or “Male” under the “Gender” category to search for female or male providers exclusively. If the “Any” option is selected, it will pull results for both male and female providers. 

    Can I filter my search to find a Non-Small Cell Lung Cancer (NSCLC) doctor that offers video calls?

    Look for the filter feature on the left-side of the Non-Small Cell Lung Cancer (NSCLC) doctor search results page. Select “Offers telehealth visits” under the Availability category to search for providers who offer virtual appointments (video calls). 

    Reviewed on: 11/11/24  

    By: MediFind Medical Staff 

    Read more about our Content Policy